New database study aims to better understand dermatomyositis skin symptoms
NCT ID NCT02945345
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study collects information from people with dermatomyositis to better understand how the disease affects their skin and quality of life. Researchers will use a special scoring tool called CDASI to measure skin changes over time. The goal is to improve knowledge about the disease and how it responds to treatments. No new drugs or therapies are being tested.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DERMATOMYOSITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hospital of the University of Pennsylvania
RECRUITINGPhiladelphia, Pennsylvania, 19104, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a targeted immune drug calm rare muscle inflammation?
- Could a simple injection dissolve painful calcium lumps in rare diseases?
- Can a skin biopsy tell your doctor which treatment will work?
- New hope for rare muscle disease: baricitinib trial aims to cut steroid use
- Scientists probe hidden clot risks in autoimmune skin disorders
- Can an online program help young people with lupus and dermatomyositis feel less stressed?